ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

5201–5220 of 6,211 studies

E3 PreliminaryDiagnosticPEM not requiredMethods-Paper

A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data.

Huang, Lung-Cheng, Hsu, Sen-Yen, Lin, Eugene·Journal of translational medicine·2009

Researchers used computer algorithms to analyze genetic variations (called SNPs) in people with ME/CFS to see if they could predict who has the disease. They tested different mathematical approaches to find the most important genes linked to ME/CFS. Their best-performing method combined a technique called naive Bayes with a process that identified the most relevant genetic markers, suggesting this approach could help identify genetic patterns in ME/CFS.

E3 PreliminaryCohortPEM not requiredCase-Control

Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea.

Veldman, Joan, Van Houdenhove, Boudewijn, Verguts, Jasper·Archives of gynecology and obstetrics·2009

This case describes a woman with chronic fatigue syndrome who developed a rare condition called membranous dysmenorrhea (where the uterine lining sheds in one piece) after starting a hormonal birth control pill. Interestingly, when she stopped the medication and the tissue was expelled, her fatigue symptoms completely disappeared and she was able to return to work. While this is just one patient's experience, it raises the possibility that hormone imbalances might contribute to chronic fatigue in some cases.

E3 PreliminaryMechanismPEM not requiredMechanistic

[Activity of hypotnalamic-pituitary-adrenal axis by induction of experimental chronic fatigue syndrom].

Fomicheva, E E, Filatenkova, T A, Rybakina, E G·Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova·2009

Researchers used an animal model to study how ME/CFS might affect the stress hormone system in the body. They gave rats a substance that mimics a viral infection, then tested whether the animals' adrenal glands (which produce cortisol, the main stress hormone) still responded normally. They found that the stress hormone system became less responsive, suggesting that an infection-like trigger could disrupt how the body regulates stress hormones.

Immune System

E3 PreliminaryMechanismPEM unclearCross-Sectional

An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome).

Puri, B K, Agour, M, Gunatilake, K D R et al.·Prostaglandins, leukotrienes, and essential fatty acids·2009

This study used brain imaging to measure levels of a protective molecule called glutathione in the brains of people with ME/CFS. Researchers had expected glutathione levels to be lower in ME/CFS patients because it was reduced in their blood, but surprisingly, the brain levels were similar between patients and healthy controls. The study found no evidence that taking glutathione supplements would help with ME/CFS brain-related symptoms.

E3 PreliminaryReviewPEM unclearReview-Narrative

Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns.

Podolecki, Tomasz, Podolecki, Andrzej, Hrycek, Antoni·Polskie Archiwum Medycyny Wewnetrznej·2009

Fibromyalgia is a condition causing widespread muscle and joint pain that affects many people worldwide. This review examines what we know about fibromyalgia's causes, how doctors diagnose it, and how it can be treated. The authors note that fibromyalgia likely results from multiple factors involving the nervous system, brain chemistry, and immune function, and that treatment typically involves antidepressants, therapy, and other approaches.

Pain and SensitizationDiagnostics

E3 PreliminaryReviewPEM unclearReview-Narrative

Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms.

Maes, Michael·Current opinion in psychiatry·2009

This review examines how inflammation and stress on cells (caused by harmful molecules) may explain ME/CFS symptoms. The authors argue that various triggers—like infections, stress, intense exercise, and a 'leaky gut'—can activate these inflammatory pathways inside cells, leading to the pain, fatigue, muscle tension, and other symptoms that ME/CFS patients experience. They suggest that treating these inflammatory pathways could help develop new medicines for ME/CFS.

Immune System

E3 PreliminaryDiagnosticPEM not requiredMethods-Paper

Continuing medical education challenges in chronic fatigue syndrome.

Brimmer, Dana J, McCleary, K Kimberly, Lupton, Teresa A et al.·BMC medical education·2009

Most doctors don't know much about ME/CFS, which means many patients don't get diagnosed or treated. Researchers created an educational program to teach healthcare providers about ME/CFS between 2000 and 2006. They found that online courses were much more popular than printed materials, and that targeting specific audiences at smaller conferences was most effective at spreading information.

E3 PreliminaryCohortPEM unclearCase-Control

On the question of infectious aetiologies for multiple sclerosis, schizophrenia and the chronic fatigue syndrome and their treatment with antibiotics.

Frykholm, B O·Medical hypotheses·2009

This small pilot study tested whether antibiotics could help patients with severe psychiatric symptoms and ME/CFS, based on the idea that certain bacteria might be involved in these conditions. Two ME/CFS patients received 60 days of antibiotics combined with vitamin B injections; one reported complete recovery and one reported significant improvement at the one-year follow-up.

E3 PreliminaryBehavioralPEM not requiredCase-Control

Fixed belief in cognitive dysfunction despite normal neuropsychological scores: neurocognitive hypochondriasis?

Boone, Kyle Brauer·The Clinical neuropsychologist·2009

Some people with ME/CFS report serious cognitive problems in their daily life, but when given standard memory and thinking tests, their scores are completely normal. This study presents one case and suggests that some patients may worry excessively about cognitive problems that aren't actually measurable on formal tests—a condition the author calls 'neurocognitive hypochondriasis.' The study notes this pattern may occur in ME/CFS and several other conditions.

Cognitive Impairment

E3 PreliminaryCohortPEM not requiredCase-Control

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Fluge, Øystein, Mella, Olav·BMC neurology·2009

This study examined whether a drug called rituximab, which reduces B cells (a type of immune cell), could help ME/CFS patients. Three ME/CFS patients received rituximab infusions and all experienced significant symptom improvement lasting several months. When symptoms returned, patients were retreated and improved again, suggesting that B cells may play a role in ME/CFS for at least some patients.

Immune System

E3 PreliminaryDiagnosticPEM not requiredMethods-Paper

Sensitive, qualitative detection of human herpesvirus-6 and simultaneous differentiation of variants A and B.

Li, Haijing, Meng, Shufang, Levine, Susan M et al.·Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2009

Researchers developed a new test to detect human herpesvirus-6 (HHV-6) in patient samples, even when the virus is present in very small amounts. The test can also tell the difference between two types of HHV-6 (called variant A and B). When tested on urine samples from people with and without chronic fatigue syndrome, the test successfully detected the virus in a small number of patients.

E3 PreliminaryBehavioralPEM not requiredCase-Control

Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity?

Friedberg, Fred, Sohl, Stephanie·Journal of clinical psychology·2009

This study looked at whether cognitive-behavioral therapy (CBT)—a type of talk therapy combined with gradually increasing physical activity—helped 11 people with ME/CFS feel better. While most patients reported feeling improved, the researchers found something surprising: some patients who felt better had actually increased their activity levels (shown by motion sensors), while others had decreased their activity levels. This suggests that improvement in ME/CFS may not work the same way the standard CBT model predicts.

E3 PreliminaryReviewPEM unclearReview-Narrative

Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?

Staines, Donald R, Brenu, Ekua W, Marshall-Gradisnik, Sonya·Neuropsychiatric disease and treatment·2009

This paper proposes that ME/CFS, along with MS, Parkinson's disease, and ALS, may involve immune system problems affecting the protective barriers around the brain and spinal cord. Specifically, the authors suggest that certain signaling molecules called PACAP and VIP, which normally help maintain these barriers, may become targets of autoimmune attack. They propose that a class of drugs called phosphodiesterase inhibitors might help restore normal function by boosting protective immune responses.

NeuroinflammationImmune System

E3 PreliminaryGuidelinePEM not requiredGuideline

Chronic fatigue syndrome: aetiology, diagnosis and treatment.

Avellaneda Fernández, Alfredo, Pérez Martín, Alvaro, Izquierdo Martínez, Maravillas et al.·BMC psychiatry·2009

ME/CFS is a serious condition marked by extreme exhaustion that lasts at least six months and doesn't improve with rest. The fatigue is so severe that it can force people to reduce their daily activities by half or more. Doctors don't yet have a single test to diagnose it, so they diagnose it by ruling out other illnesses. There is currently no cure, but treatment works best when doctors, mental health professionals, and social support services work together to help patients.

Post-Exertional Malaise

E3 PreliminaryCohortPEM not requiredCross-Sectional

Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra.

Sakudo, Akikazu, Kuratsune, Hirohiko, Kato, Yukiko Hakariya et al.·Clinica chimica acta; international journal of clinical chemistry·2009

Researchers used a special infrared scanner to examine fingernails from people with ME/CFS and compared them to healthy people's nails. They found that the proteins in ME/CFS patients' nails had different structures—specifically, the nails showed less of a protein structure called alpha-helix and more of a structure called beta-sheet. This suggests that ME/CFS may cause measurable changes in nail composition that could potentially be detected with this scanning technology.

Biomarkers

E3 PreliminaryMechanismPEM not requiredMechanistic

Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming.

Kuo, Yao-Haur, Tsai, Wei-Jern, Loke, Soy-Hwee et al.·Journal of ethnopharmacology·2009

This study tested whether a natural plant supplement called Astragalus membranaceus flavonoids (AMF) could help rats with chronic fatigue caused by stress and food restriction. The rats that received AMF showed improvements in immune function, better energy for swimming, and restored normal immune system balance compared to untreated fatigued rats.

Immune System

E3 PreliminaryDiagnosticPEM not requiredCross-Sectional

Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies.

Kuwabara, Natsuko, Itoh, Yasuhiko, Igarshi, Tohru et al.·Autoimmunity·2009

This study found that a specific antibody called anti-Sa, detected in people with chronic fatigue and positive autoimmune markers, is actually targeting a protein called LEDGF/p75. Researchers developed a simple blood test (ELISA) to detect this antibody more accurately than previous methods. This new test could help doctors identify which patients with chronic fatigue may have an autoimmune component to their illness.

Immune System

E3 PreliminaryCohortPEM not requiredCross-Sectional

Practice Nurses' views of their role in the management of Chronic Fatigue Syndrome/Myalagic Encephalitis: a qualitative study.

Chew-Graham, Carolyn, Dixon, Rebecca, Shaw, Jonathan W et al.·BMC nursing·2009

This study asked 29 practice nurses (nurses who work in doctor's offices) about their understanding and views of ME/CFS. The researchers found that most nurses knew very little about ME/CFS, had not received formal training, and some held negative attitudes toward the condition. While nurses thought they could help manage ME/CFS patients, they often didn't understand the best evidence-based treatments available.

E3 PreliminaryDiagnosticPEM not requiredMethods-Paper

Web usage data as a means of evaluating public health messaging and outreach.

Tian, Hao, Brimmer, Dana J, Lin, Jin-Mann S et al.·Journal of medical Internet research·2009

This study looked at how many people visited the CDC's ME/CFS website over 18 months and what information they searched for. The website received millions of visits from around the world, showing that many people are looking for reliable information about ME/CFS. The researchers found that a public awareness campaign successfully brought more visitors to the site, and that people were more interested in professional medical information after the campaign ended.

E3 PreliminaryCohortPEM not requiredCase-Control

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.

Exley, Christopher, Swarbrick, Louise, Gherardi, Rhomain K et al.·Medical hypotheses·2009

This study describes one patient who developed both chronic fatigue syndrome (ME/CFS) and a muscle condition called macrophagic myofasciitis after receiving vaccines containing aluminum adjuvants, and who also had high levels of aluminum in their body. The researchers propose that aluminum accumulation from vaccines might trigger immune system problems that lead to these conditions. This is a single case report rather than a broad study of many patients.

Immune System

← Previous Next 20 studies →

Or browse by topic

PEM Immune Neuro Metabolic Biomarkers Severe ME Long COVID Cognitive

Evidence Atlas

Evidence browser

A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data.

Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea.

[Activity of hypotnalamic-pituitary-adrenal axis by induction of experimental chronic fatigue syndrom].

An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome).

Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns.

Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms.

Continuing medical education challenges in chronic fatigue syndrome.

On the question of infectious aetiologies for multiple sclerosis, schizophrenia and the chronic fatigue syndrome and their treatment with antibiotics.

Fixed belief in cognitive dysfunction despite normal neuropsychological scores: neurocognitive hypochondriasis?

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Sensitive, qualitative detection of human herpesvirus-6 and simultaneous differentiation of variants A and B.

Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity?

Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?

Chronic fatigue syndrome: aetiology, diagnosis and treatment.

Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra.

Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming.

Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies.

Practice Nurses' views of their role in the management of Chronic Fatigue Syndrome/Myalagic Encephalitis: a qualitative study.

Web usage data as a means of evaluating public health messaging and outreach.

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research